Cogniss opens new UK with new global headquarters in Cambridge
Posted:
Cogniss, a no-code ecosystem for digital health, has launched its new global headquarters in Cambridge, UK, as the tech company's growing user base of health innovators accelerates in the UK and Europe.
The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.
Read more here.
OpenAI launched ChatGPT Health and Anthropic added medical toolsets for Claude, meaning users can sync their records and wearables, using their personal health data to get hyper-specific answers to their medical questions. At the same time, the FDA issued new guidance…
Attendees
Sponsors and Exhibitors
Contact us